EP 4097133 A1 20221207 - ANTI-G-PROTEIN ALPHA ANTIBODY
Title (en)
ANTI-G-PROTEIN ALPHA ANTIBODY
Title (de)
ANTI-G-PROTEIN-ALPHA-ANTIKÖRPER
Title (fr)
ANTICORPS ANTI-PROTEINE G ALPHA
Publication
Application
Priority
- FR 2000923 A 20200130
- FR 2021050164 W 20210129
Abstract (en)
[origin: WO2021152266A1] The invention relates to antibodies or an antibody fragment capable of binding to G-protein alpha, to nucleic acid sequences encoding the antibody, to vectors comprising the nucleic acid sequence, to cells comprising the vector or the nucleic acid sequence and to a reagent kit comprising (i) the antibody or the antibody fragment or the composition and (ii) a source of GTP labelled with a member of a pair of RET partners.
IPC 8 full level
C07K 16/28 (2006.01); G01N 33/542 (2006.01); G01N 33/566 (2006.01); G01N 33/573 (2006.01); G01N 33/577 (2006.01)
CPC (source: EP US)
C07K 16/28 (2013.01 - EP US); C12N 15/63 (2013.01 - US); G01N 33/53 (2013.01 - US); G01N 33/542 (2013.01 - EP); G01N 33/5735 (2013.01 - EP); C07K 2317/565 (2013.01 - US); G01N 2333/4719 (2013.01 - EP US); G01N 2333/726 (2013.01 - EP US); G01N 2500/02 (2013.01 - EP)
Citation (search report)
See references of WO 2021152266A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021152266 A1 20210805; CA 3166591 A1 20210805; CN 115397858 A 20221125; EP 4097133 A1 20221207; FR 3106830 A1 20210806; FR 3106830 B1 20220211; JP 2023511770 A 20230322; US 2023091315 A1 20230323
DOCDB simple family (application)
FR 2021050164 W 20210129; CA 3166591 A 20210129; CN 202180026754 A 20210129; EP 21707328 A 20210129; FR 2000923 A 20200130; JP 2022546606 A 20210129; US 202117796375 A 20210129